Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-03

FDA Approved: SILODOSIN — Original Application (Creekwood Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Creekwood Pharmaceuticals LLC's original application for silodosin. The drug is indicated for treatment of urinary symptoms due to benign prostatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

ORIG AP for SILODOSIN (SILODOSIN)